These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17910109)

  • 1. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients.
    Basu A; Heckman JJ; Navarro-Lozano S; Urzua S
    Health Econ; 2007 Nov; 16(11):1133-57. PubMed ID: 17910109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.
    Hadley J; Polsky D; Mandelblatt JS; Mitchell JM; Weeks JC; Wang Q; Hwang YT;
    Health Econ; 2003 Mar; 12(3):171-86. PubMed ID: 12605463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods.
    Brooks JM; Chrischilles EA
    Med Care; 2007 Oct; 45(10 Supl 2):S123-30. PubMed ID: 17909370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the current Medicare reimbursement system for breast cancer operations.
    Lucci A; Shoher A; Sherman MO; Azzizadeh A
    Ann Surg Oncol; 2004 Dec; 11(12):1037-44. PubMed ID: 15545504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.
    Basu A
    Stat Biosci; 2011 Sep; 3(1):6-27. PubMed ID: 22010051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
    Brooks JM; Fang G
    Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
    Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL
    Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare breast surgery fees and treatment received by older women with localized breast cancer.
    Hadley J; Mandelblatt JS; Mitchell JM; Weeks JC; Guadagnoli E; Hwang YT;
    Health Serv Res; 2003 Apr; 38(2):553-73. PubMed ID: 12785561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are many community hospitals undertreating breast cancer?: lessons from 24,834 patients.
    Gutierrez JC; Hurley JD; Housri N; Perez EA; Byrne MM; Koniaris LG
    Ann Surg; 2008 Aug; 248(2):154-62. PubMed ID: 18650623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects.
    Harris KM; Remler DK
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1337-60. PubMed ID: 9865223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
    Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed care enrollment and chronically disabled women with breast cancer.
    Habermann EB; Virnig BA; Durham SB; Baxter NN
    Am J Manag Care; 2008 Aug; 14(8):514-20. PubMed ID: 18690767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-course radiotherapy for the whole breast after breast conserving surgery.
    Nozaki M; Kawashima M
    Breast Cancer; 2008; 15(1):80-5. PubMed ID: 18224400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.